Cargando…

Comprehensive Grading System for Experimental Autoimmune Uveitis in Mice

Experimental autoimmune uveitis (EAU) is the most commonly used animal model to study the progression of chronic uveitis and to test various therapies to treat the disease. However, to accurately evaluate the effectiveness of such treatments, a grading system that combines the latest imaging techniq...

Descripción completa

Detalles Bibliográficos
Autores principales: Shome, Avik, Mugisho, Odunayo O., Niederer, Rachael L., Rupenthal, Ilva D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377264/
https://www.ncbi.nlm.nih.gov/pubmed/37509662
http://dx.doi.org/10.3390/biomedicines11072022
_version_ 1785079474814976000
author Shome, Avik
Mugisho, Odunayo O.
Niederer, Rachael L.
Rupenthal, Ilva D.
author_facet Shome, Avik
Mugisho, Odunayo O.
Niederer, Rachael L.
Rupenthal, Ilva D.
author_sort Shome, Avik
collection PubMed
description Experimental autoimmune uveitis (EAU) is the most commonly used animal model to study the progression of chronic uveitis and to test various therapies to treat the disease. However, to accurately evaluate the effectiveness of such treatments, a grading system that combines the latest imaging techniques with definitive quantitative grading thresholds is required. This study aimed to develop a comprehensive grading system that objectively evaluates EAU progression in C57BL/6J mice. EAU was induced following immunisation with interphotoreceptor retinoid-binding protein (IRBP) and pertussis toxin. Weekly fundus and optical coherence tomography (OCT) images were acquired over 12 weeks using a Micron IV imaging system. Each mouse was graded (between 0 to 4) based on changes seen on both the fundus (optic disc, retinal blood vessels and retinal tissue) and OCT (vitreous and retinal layers) images. A total EAU response (with a maximum score of 48) was calculated for each mouse based on the sum of the individual scores each week. Analysis of the clinical scores depicted a gradual increase in inflammatory signs including optic disc and vascular swelling, leukocyte infiltration in the vitreous, lesions in the retina and formation of granulomas and hyper-reflective foci in the retinal layers in EAU mice, with most signs reaching a plateau towards the end of the study period. Development of these signs into sight-threatening complications such as optic disc atrophy, structural damage to the retina and subretinal oedema were noted in 80–90% of mice suggesting consistent disease induction. Overall, a comprehensive and objective grading system encompassing all pathologies occurring in EAU mice was developed to enhance the preclinical evaluation of novel uveitis treatments.
format Online
Article
Text
id pubmed-10377264
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103772642023-07-29 Comprehensive Grading System for Experimental Autoimmune Uveitis in Mice Shome, Avik Mugisho, Odunayo O. Niederer, Rachael L. Rupenthal, Ilva D. Biomedicines Article Experimental autoimmune uveitis (EAU) is the most commonly used animal model to study the progression of chronic uveitis and to test various therapies to treat the disease. However, to accurately evaluate the effectiveness of such treatments, a grading system that combines the latest imaging techniques with definitive quantitative grading thresholds is required. This study aimed to develop a comprehensive grading system that objectively evaluates EAU progression in C57BL/6J mice. EAU was induced following immunisation with interphotoreceptor retinoid-binding protein (IRBP) and pertussis toxin. Weekly fundus and optical coherence tomography (OCT) images were acquired over 12 weeks using a Micron IV imaging system. Each mouse was graded (between 0 to 4) based on changes seen on both the fundus (optic disc, retinal blood vessels and retinal tissue) and OCT (vitreous and retinal layers) images. A total EAU response (with a maximum score of 48) was calculated for each mouse based on the sum of the individual scores each week. Analysis of the clinical scores depicted a gradual increase in inflammatory signs including optic disc and vascular swelling, leukocyte infiltration in the vitreous, lesions in the retina and formation of granulomas and hyper-reflective foci in the retinal layers in EAU mice, with most signs reaching a plateau towards the end of the study period. Development of these signs into sight-threatening complications such as optic disc atrophy, structural damage to the retina and subretinal oedema were noted in 80–90% of mice suggesting consistent disease induction. Overall, a comprehensive and objective grading system encompassing all pathologies occurring in EAU mice was developed to enhance the preclinical evaluation of novel uveitis treatments. MDPI 2023-07-18 /pmc/articles/PMC10377264/ /pubmed/37509662 http://dx.doi.org/10.3390/biomedicines11072022 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Shome, Avik
Mugisho, Odunayo O.
Niederer, Rachael L.
Rupenthal, Ilva D.
Comprehensive Grading System for Experimental Autoimmune Uveitis in Mice
title Comprehensive Grading System for Experimental Autoimmune Uveitis in Mice
title_full Comprehensive Grading System for Experimental Autoimmune Uveitis in Mice
title_fullStr Comprehensive Grading System for Experimental Autoimmune Uveitis in Mice
title_full_unstemmed Comprehensive Grading System for Experimental Autoimmune Uveitis in Mice
title_short Comprehensive Grading System for Experimental Autoimmune Uveitis in Mice
title_sort comprehensive grading system for experimental autoimmune uveitis in mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377264/
https://www.ncbi.nlm.nih.gov/pubmed/37509662
http://dx.doi.org/10.3390/biomedicines11072022
work_keys_str_mv AT shomeavik comprehensivegradingsystemforexperimentalautoimmuneuveitisinmice
AT mugishoodunayoo comprehensivegradingsystemforexperimentalautoimmuneuveitisinmice
AT niedererrachaell comprehensivegradingsystemforexperimentalautoimmuneuveitisinmice
AT rupenthalilvad comprehensivegradingsystemforexperimentalautoimmuneuveitisinmice